Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 2 of 18
RHI Interval Effects on Brain Health
NCT07010887
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
NCT07119658
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
NCT06996951
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis
NCT06642610
ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
NCT06915038
Effect of the HCC Liver-Link Intervention
NCT06728293
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
NCT06982105
Cervical Myelopathy in Hip Fracture Patients
NCT06893406
Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy
NCT06921148
Ondansetron for the Management of Atrial Fibrillation
NCT05844501
Effect of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Plasma Insulin Levels
NCT06597149
Ultrasound Acute Chest Syndrome Sickle Cell Disease
NCT06880679
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
NCT06541886
Menthol Stimulation of Brown Adipose Tissue in Humans: Aim 1
NCT07030725
Attenuating DEPression With Internet CBT to Slow Cognitive Decline in Older ICU Survivors(ADEPT-ICU)
NCT06627894
Predictive Modeling for Social Needs in Emergency Department Settings
NCT06655974
NearWave Optical Molecular Monitoring
NCT06744465
Ketone Ester And Salt (KEAS) in Older Adults
NCT06868719
Evaluating Tolerability of ePUHRT With Brachytherapy Boost
NCT06817668
Modulation of Motor Learning Via tDCS in a Dexterous Video Game Task
NCT07202702
Omega-3 Fatty Acids and Subconcussive Head Impacts
NCT06736925
Effects of Virtual Reality Relaxation on the Anxiety Levels
NCT06804967
Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction
NCT06784999
Use of Eye Tracking to Aid in Autism Risk Detection
NCT06471504
Nicotinic Acid for the Treatment of Alzheimer's Disease
NCT06582706
Smart Pillows for Enhancing Sleep Quality
NCT06594627
Exploring the Acute and Dynamic Relationships Between Movement and Pain in Older Adults With Musculoskeletal Pain
NCT06886906
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
NCT06493032
Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma
NCT06561321
Exercise as Maintenance Therapy in Advanced Lung Cancer
NCT06513663
High vs Low-frequency of High-intensity Training in Chronic Stroke
NCT06612723
Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
NCT06593665
Telephone Support in Advanced Gastrointestinal Cancer
NCT06532877
Leg Heat Therapy in Heart Failure With Preserved Ejection Fraction
NCT06388226
Equipping Patients Using Interventions for Pain and Depression
NCT06500780
Acoustic Waveform Respiratory Evaluation
NCT06512064
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
NCT06403345
Enhancing Prospective Thinking in Early Recovery (BEAM)
NCT06283472
Hospital @ Home Model of Care for Cirrhosis
NCT06396897
Acupressure in Patients With Sickle Cell Disease
NCT06511453
Measuring Patient Reported Needs in Outpatient Liver Disease Management
NCT07191886
Enhancing Prospective Thinking in Early Recovery (HOME)
NCT06302413
Evaluating Disparities in Precision Oncology
NCT06081517
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
NCT06059586
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
NCT05573490
The Prevalence of Neuropathic Pain Pathophysiology Associated With Ankle Fracture
NCT06420141
rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant Depression
NCT06511544
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
NCT05879913
Simultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates
NCT05717842
Increasing Equity in Lung Cancer Screening
NCT06360822
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.